VANCOUVER, BC and TORONTO, May 11, 2023 /CNW/ - BZAM Ltd. (the "Company" or "BZAM") (CSE: BZAM) (US-OTC: BZAMF), a leading Canadian cannabis producer, is pleased to announce that its subsidiary, The Green Organic Dutchman Ltd, has received EU GMP certification for the Company's facility located in Ancaster, Ontario. This certification permits the Company to export certain medicinal cannabis products to numerous global markets. The certification is valid for a three-year period from inspection, with a renewal date of August 31, 2025.

This certification allows BZAM to execute on existing strategic distribution partnerships which have already been established, including partnerships in Germany and the UK. With regard to the UK, the Company anticipates launching multiple strains under The Green Organic Dutchman brand in Q4 2023.

Matt Milich, CEO, stated: "We are thrilled to announce this significant milestone for the Company. Having laid the groundwork with key partners in Germany and the UK, we are ready to hit the ground running as we continue expanding our distribution network in the additional markets this opens up. We couldn't be more excited to share some of Canada's best cannabis with our friends in Europe." 

With Germany's recent moves toward legalising cannabis for recreational use, BZAM is now well positioned to benefit from regulatory changes as they unfold. The Company expects to see a positive impact on revenue from international sales resulting from EU GMP certification by Q4 2023, if not sooner.

BZAM Ltd. (CSE: BZAM) (OTC: BZAMF) is a leading Canadian cannabis producer with a focus on branded consumer goods, innovation, quality, consistency, integrity, sustainability and transparency. The BZAM family includes core brands BZAM™, TGOD™, ness™, Highly Dutch Organic™, TABLE TOP™, and partner brands Dunn Cannabis, FRESH and Wyld. BZAM operates facilities in BC, Alberta, Ontario and Quebec, as well as retail stores in Winnipeg, Manitoba and Regina, Saskatchewan.

BZAM's Common Shares and certain warrants issued under the indentures dated June 12, 2020, October 23, 2020, and December 10, 2020, currently trade on the Canadian Securities Exchange (the "CSE") under the symbol "BZAM". BZAM's Common Shares trade in the U.S. on the OTCQX under the symbol "BZAMF". For more information, please visit www.bzam.com

This news release includes statements containing certain "forward–looking information" within the meaning of applicable securities law ("forward–looking statements"). Forward looking statements in this release include, but are not limited to, statements about future production quantity and timing, statements about the offering of any particular products by the Company and statements regarding the future performance of the Company, statements about funding availability, statements about growth and delivery of products, and statements about the level of demand for BZAM's products, statements about future legalization of recreational cannabis in Germany, statements relating to the creation and timing of any revenue in Germany and the UK, and statements about the future size of any international markets. Forward–looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "should", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions.  Various assumptions were used in drawing the conclusions or making the projections contained in the forward–looking statements throughout this news release, such as assumptions that the Company's financial trajectory will continue, the Company not having any issues with regulators, cultivation patterns at the Company's facilities continuing and there not being significant disruptions in cultivation such as disease or shortages in resources, the Company being insulated from supply chain issues and inflation affecting the global economy, the Company being able to access the capital markets and existing lenders for necessary funding, when necessary, demand for the Company's products continuing as expected and based on past trends. Forward–looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties (including market conditions) and other factors that could cause actual events or results to differ materially from those projected in the forward–looking statements, including those risk factors described in Management's Discussion and Analysis and the Company's most recent Annual Information Form filed with Canadian securities regulators and available on the Company's issuer profile on SEDAR at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward–looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither the CSE nor the CSE's Regulation Services Provider (as that term is defined in the policies of CSE) accept responsibility for the adequacy or accuracy of this release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/bzam-ltd-receives-eu-gmp-certification-approval-301822132.html

SOURCE BZAM LTD.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2023/11/c9545.html